TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pensa Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/03 | 2021/12 | 2020/12 |
Turnover |
2,836
|
3,837
|
2,235 |
Financial expenses |
9
|
0
|
14 |
Earnings before taxes |
-329
|
105
|
44 |
EBITDA |
-295
|
98
|
59 |
Total assets |
2,537
|
2,847
|
3,513 |
Current assets |
1,996
|
1,733
|
2,670 |
Current liabilities |
911
|
684
|
1,359 |
Equity capital |
1,626
|
2,164
|
2,154 |
- share capital |
89
|
98
|
100 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/03 | 2021/12 | 2020/12 |
Solvency |
64.1%
|
76.0%
|
61.3% |
Turnover per employee | |||
Profit as a percentage of turnover |
-11.6%
|
2.7%
|
2.0% |
Return on assets (ROA) |
-12.6%
|
3.7%
|
1.7% |
Current ratio |
219.1%
|
253.4%
|
196.5% |
Return on equity (ROE) |
-20.2%
|
4.9%
|
2.0% |
Change turnover |
-644
|
1,643
|
260 |
Change turnover % |
-19%
|
75%
|
13% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/03 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.